Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
AquaBounty Technologies (AQB): Could Shares Reach $1.50 (+58% Upside)?

AquaBounty Technologies (AQB): Could Shares Reach $1.50 (+58% Upside)?

Key Takeaways

  • The $1.50 central target is a fallback objective drawn from public market and technical discussion, not an analyst consensus, because AQB has no credible, current sell-side price targets.
  • With the stock near $0.95, reaching $1.50 would require roughly 58% upside, a very large move for a company that has wound down its core aquaculture operations.
  • There is effectively no usable analyst coverage today: data providers list zero to one stale targets, and the last meaningful ratings predate the company's operational wind-down.
  • The strongest potential supports are a completed strategic transaction for its Ohio property and the stock's extreme volatility, which has produced large short-term swings.
  • The biggest risks are a going-concern warning, roughly $1.9 million in cash, highly dilutive preferred financing, and renewed Nasdaq delisting risk.
  • For additional context, explore the ticker's Major News, Today's Price Move, Forecast, and Earnings pages.
  • Readers seeking systematic, AI-driven trade ideas can also review Tickeron's Trending AI Robots.

Analyst Coverage and the Fallback Price Target

AQB is a micro-cap land-based aquaculture company best known for developing AquAdvantage, a genetically engineered Atlantic salmon. After years of losses and cost overruns, it shut down its Indiana farm, paused the unfinished Ohio Farm Project, and shifted to selling assets and pursuing strategic alternatives. That restructuring has left the stock essentially without analyst coverage: TipRanks lists zero analysts with a 12-month price target, and the last substantive ratings — including a "Neutral" from H.C. Wainwright and "Market Perform" from Oppenheimer in 2024 — predate the wind-down. A single stale $1.00 target dated November 2024 remains in some databases, but it is not a usable, current consensus.

Because no credible aggregate analyst price target exists, the $1.50 figure used here is a fallback objective grounded in public technical discussion rather than a published consensus. It sits meaningfully above the $1.00 Nasdaq minimum-bid threshold the company was required to clear, and it lies within the stock's 52-week trading range, which has reached roughly $2.95. It should be read as a speculative, recovery-scenario milestone — not a forecast any analyst has formally published. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

Shares have traded near $0.95, leaving the company with a market value of only a few million dollars. Reaching $1.50 would require approximately 58% appreciation, which is best described as a very large move for any security, even this highly volatile one. The path would depend less on fundamentals than on two catalysts: securing financing and completing a value-creating transaction for the Ohio property. In 2026 management expanded its strategic review to include power generation, digital infrastructure, and energy development uses for the Pioneer, Ohio site — a significant departure from aquaculture. Any credible monetization of that real estate, or a new capital injection, could support a sharp repricing, while continued inaction would likely pressure the shares.

What Could Support a Move Toward the Target

  • A completed sale, lease, or joint-venture for the Ohio site, including potential energy or data-center uses, which could unlock value from otherwise idle assets.
  • The company's demonstrated ability to regain Nasdaq compliance in September 2025, and its past capacity to draw speculative buying interest on news-driven momentum.
  • Extreme share-price volatility: the stock has swung between roughly $0.70 and $2.95 over the past year, meaning outsized percentage moves are not unprecedented.
  • Reduced losses from asset sales and lower impairments, which have narrowed reported losses even as revenue effectively disappeared.

What Could Prevent the Target From Being Reached

  • A going-concern warning: with roughly $1.9 million in cash and cumulative losses in the hundreds of millions, management has stated there is substantial doubt about the company's ability to continue within a year.
  • Heavily dilutive preferred-stock financing in 2026, including convertible securities with a high cumulative dividend, which can dilute common holders and weigh on the share price.
  • Delisting risk: a proposed Nasdaq rule requiring a $5 million minimum market value of listed securities could trigger suspension, and the company's market value has hovered near or below that level.
  • The absence of an operating business generating meaningful revenue, leaving the stock dependent on deal outcomes rather than earnings.

Technical Levels and Market Structure

The $1.00 level functions as both a psychological mark and a regulatory compliance threshold, making it a key area to watch; sustained trading below it would refocus attention on listing risk. Above that, $1.50 represents the next round-number resistance zone used here as the target. The 52-week high near $2.95 marks the upper bound of recent trading, while support has formed near the $0.70–$0.77 lows. With very thin average volume and a micro-cap float, technical levels are especially fragile and prone to gap moves. From what I see, the volatility patterns here are worth monitoring closely with automated tools.

Time Horizon and What Investors Should Monitor

Because no formal analyst target exists, there is no standard 12-month research horizon to reference; the $1.50 level is a milestone rather than a dated forecast. Investors should monitor the company's quarterly filings and cash balance, any update on the Ohio strategic review and potential energy or infrastructure transaction, further preferred or equity financing and its dilution, and Nasdaq listing-status developments, including the proposed market-value rule. Earnings releases and 8-K filings remain the primary sources of material news for a company with minimal sell-side coverage.

Exploring Tickeron’s AI Daily Buy/Sell Signals

In my view, Tickeron's AI Daily Buy/Sell Signals offer a practical way to stay on top of names like AQB. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a volatile, low-liquidity name such as AQB, automated monitoring can help traders spot changing trends, manage open positions, and surface opportunities more efficiently than manual review. Traders can use the tool to complement their own research and stay alert to momentum shifts across the broader market. I find it especially helpful when reviewing technical setups for micro-cap names where liquidity is thin.

Final Assessment

Can AQB reach $1.50? The target is not an analyst-derived consensus but a speculative technical milestone roughly 58% above the recent price. A move of that size is conceivable given the stock's extreme volatility, but it would almost certainly require a transformative event — a monetization of the Ohio property or a substantial capital injection — rather than an improvement in operating fundamentals, because the company's legacy salmon business has been largely wound down. Against that, investors must weigh the going-concern warning, a thin cash position, dilutive financing, and genuine delisting risk. The balance of evidence is cautious, and the outcome will depend on corporate actions and financing rather than earnings. No price target or forecast should be treated as a guarantee.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AQB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AQB sees MACD Histogram crosses below signal line

AQB saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 05, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 38 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AQB as a result. In 82 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

AQB moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AQB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

AQB broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AQB's RSI Oscillator exited the oversold zone, 36 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for AQB crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Following a +8.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AQB advanced for three days, in 155 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 64 of 85 cases where AQB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.793) is normal, around the industry mean (2.266). P/E Ratio (-0.214) is within average values for comparable stocks, (4.366). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). AQB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (2.089) is also within normal values, averaging (2.353).

The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. AQB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AQB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Archer Daniels Midland Company (NYSE:ADM), Tyson Foods (NYSE:TSN), Cal-Maine Foods (NASDAQ:CALM).

Industry description

The Agricultural Commodities/Milling industry includes companies that are involved in farming activities, such as crop production, livestock management and animal feed, for commercial purposes. The industry includes a wide range of operations from growing corn, to grain and oilseed processing to the operation of flour mills. Changes in consumer tastes is one of the critical factors influencing what products are grown and raised in this industry. Potential risks to the business include climate change and fluctuations in global prices of agricultural products. Archer-Daniels-Midland Company, Elanco Animal Health, Inc., Bunge Limited and Canopy Growth Corporation are some of the biggest U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Agricultural Commodities/Milling Industry is 4.13B. The market cap for tickers in the group ranges from 700 to 34.75B. HPTYD holds the highest valuation in this group at 34.75B. The lowest valued company is VCEX at 700.

High and low price notable news

The average weekly price growth across all stocks in the Agricultural Commodities/Milling Industry was -1%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -14%. SDOT experienced the highest price growth at 13%, while PFAI experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Agricultural Commodities/Milling Industry was 20%. For the same stocks of the Industry, the average monthly volume growth was 29% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 43
P/E Growth Rating: 58
Price Growth Rating: 64
SMR Rating: 92
Profit Risk Rating: 90
Seasonality Score: 3 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company focused on improving productivity in commercial aquaculture

Industry AgriculturalCommoditiesMilling

Industry
Biotechnology
Address
233 Ayer Road
Phone
+1 978 648-6000
Employees
4
Web
https://www.aquabounty.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.
CCAP climbed +7.03% during regular market hours, rising from a prior close of $9.24 to $9.89. The rally followed its Q3 2026 report: net investment income of $0.37/share beat the $0.35 consensus and revenue of $36.9M topped estimates, alongside a new $50M buyback authorization plus up to $25M in additional Sun Life purchases.
AquaBounty Technologies (AQB): Could Shares Reach $1.50 (+58% Upside)?